Trump

Market Access

Shrugging off warnings from president Donald Trump, pharma companies have announced US price hikes on more than 250 prescription drugs for 2019.

News

Pfizer has decided to defer the recent drug price increase after a long discussion with president Trump and HHS secretary.

News

Declaration means potential more resources and power to states and federal agencies.

News

Final vote results in slim loss of 51-49 for Obamacare repeal bill.

News

Spokesman also causes confusion over pricing policy.

News

AstraZeneca saw revenues decline by 3% and earnings per share fall 5% in 2016 as the expiry of blockbuster Crestor took its toll.